Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | CCR1 | P32246 | 1/20 | 0.47 |
| ▸ | CCR5 | P51681 | 1/20 | 0.47 |
| ▸ | CCR8 | P51685 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 3/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL198406 | 0.84 | CCR1 (0.54) | NPC1RAB9ASMN1; SMN2GLAKDM4E | |
| SCHEMBL21274954 | 0.77 | CCR1 (0.52) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL8008287 | 0.77 | GRM5 (0.56) | NPC1RAB9ASMN1; SMN2GLAKDM4E | |
| SCHEMBL19132920 | 0.77 | KDM4E (0.44) | NPC1RAB9ASMN1; SMN2GLAKDM4E | |
| SCHEMBL15849062 | 0.77 | KMT2A (0.61) | NPC1RAB9ASMN1; SMN2GLAKDM4E | |
| SCHEMBL254803 | 0.76 | NOTUM (0.63) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL29635591 | 0.76 | NOTUM (0.63) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL27129458 | 0.75 | MAPT (0.46) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL24920821 | 0.75 | KDM4E (0.43) | NPC1RAB9ASMN1; SMN2GLAKDM4E | |
| SCHEMBL24920393 | 0.75 | CCR1 (0.53) | NPC1RAB9ACYP1A2CYP2C19CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025040546-A1 | PYRAZOLE COMPOUNDS AS CULLIN RING UBIQUITIN LIGASE COMPOUNDS | PROXYGEN GMBH (AT) | 2025-02-27 | — | — | WO | disclosed |
| US-20240376513-A1 | ELECTROCHEMICAL BIOSENSOR, OR SENSING MEMBRANE FOR ELECTROCHEMICAL BIOSENSOR CONTAINING TRANSITION METAL COMPLEX OR OXIDATION-REDUCTION POLYMER | I-SENS, INC. (KR) | 2024-11-14 | — | — | US | disclosed |
| EP-4328232-A1 | ELECTROCHEMICAL BIOSENSOR, OR SENSING MEMBRANE FOR ELECTROCHEMICAL BIOSENSOR CONTAINING TRANSITION METAL COMPLEX OR OXIDATION-REDUCTION POLYMER | I-SENS, INC. (KR) | 2024-02-28 | — | — | EP | disclosed |
| EP-4328232-A1 | ELECTROCHEMICAL BIOSENSOR, OR SENSING MEMBRANE FOR ELECTROCHEMICAL BIOSENSOR CONTAINING TRANSITION METAL COMPLEX OR OXIDATION-REDUCTION POLYMER | I-SENS, INC. (KR) | 2024-02-28 | — | — | EP | disclosed |
| CN-117242084-A | Electrochemical biosensor comprising transition metal complex or redox polymer or sensing membrane for electrochemical biosensor | 爱-森新株式会社 | 2023-12-15 | — | — | CN | disclosed |
| WO-2023006097-A1 | BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER | 海创药业股份有限公司 | 2023-02-02 | — | — | WO | disclosed |
| WO-2022225313-A1 | ELECTROCHEMICAL BIOSENSOR, OR SENSING MEMBRANE FOR ELECTROCHEMICAL BIOSENSOR CONTAINING TRANSITION METAL COMPLEX OR OXIDATION-REDUCTION POLYMER | 주식회사 아이센스 | 2022-10-27 | — | — | WO | disclosed |
| CN-103201261-A | Lactam derivatives as orexin receptor antagonists | ACTELION PHARMACEUTICALS LTD | 2013-07-10 | — | — | CN | disclosed |
| CN-102762567-A | Diaza-spiro[5.5]undecanes as orexin receptor antagonists | NOVARTIS AG | 2012-10-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240376513-A1 | ELECTROCHEMICAL BIOSENSOR, OR SENSING MEMBRANE FOR ELECTROCHEMICAL BIOSENSOR CONTAINING TRANSITION METAL COMPLEX OR OXIDATION-REDUCTION POLYMER | OXA1L, PDK1, SLC2A3 | NPC1 4604/4885RAB9A 3858/4885SMN1; SMN2 4611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.